J1453 HCPCS Level II code: Injection, fosaprepitant, 1 mg
J1453 is the HCPCS code for “Injection, fosaprepitant, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1453Injection, fosaprepitant, 1 mg
Short description: Fosaprepitant injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1453 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2009
Where J1453 sits
- 1J codesDrugs administered other than orally
- 2Active code J1453Injection, fosaprepitant, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1453 mean?
J1453 is the HCPCS code for “Injection, fosaprepitant, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1453?
CMS lists J1453’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1453
All J codesJ1447Injection, tbo-filgrastim, 1 microgramJ1448Injection, trilaciclib, 1mgJ1449Injection, eflapegrastim-xnst, 0.1 mgJ1450Injection fluconazole, 200 mgJ1451Injection, fomepizole, 15 mgJ1452Injection, fomivirsen sodium, intraocular, 1.65 mgJ1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mgJ1455Injection, foscarnet sodium, per 1000 mgJ1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mgJ1457Injection, gallium nitrate, 1 mgJ1458Injection, galsulfase, 1 mgJ1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg